www.impactjournals.com/oncotarget/ Oncotarget, 2016, Vol. 7, (No. 50), pp: 83278-83293 Research Paper ERN1 and ALPK1 inhibit differentiation of bi-potential tumor- initiating cells in human breast cancer Juliane Strietz2,*, Stella S. Stepputtis2,3,*, Bogdan-Tiberius Preca2,3,*, Corinne Vannier2,3, Mihee M. Kim1, David J. Castro1, Qingyan Au1, Melanie Boerries3,5, Hauke Busch3,5, Pedro Aza-Blanc1, Susanne Heynen-Genel1, Peter Bronsert8,9,10, Bernhard Kuster6, Elmar Stickeler7, Thomas Brabletz4, Robert G. Oshima1,#, Jochen Maurer1,2,3,# 1Cancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA 2Department of Visceral Surgery, University Hospital Freiburg, German Cancer Consortium (DKTK), Freiburg, Germany 3German Cancer Research Center (DKFZ), Heidelberg, Germany 4Department of Experimental Medicine I, University of Erlangen-Nuernberg, Erlangen, Germany 5 Systems Biology of the Cellular Microenvironment at The DKFZ Partner Site Freiburg, German Cancer Consortium (DKTK), Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany 6Technische Universitaet Muenchen, Partner Site of the German Cancer Consortium, Freising, Germany 7Department of OBGYN, University Clinic Aachen (UKA), Aachen, Germany 8Department of Surgical Pathology, University Medical Center Freiburg, Freiburg, Germany 9German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany 10Institute of Pathology, University Medical Center Freiburg, Freiburg, Germany *These authors have contributed equally and share first authorship #These authors have contributed equally and share last authorship Correspondence to: Jochen Maurer, email:
[email protected] Robert G. Oshima, email:
[email protected] Keywords:ALPK1, ERN1, differentiation therapy, human bi-potential tumor-initiating cells, kinase knockdown Received: March 21, 2016 Accepted: October 21, 2016 Published: November 04, 2016 ABSTRACT Cancers are heterogeneous by nature.